ICD-10-CM Billable Code

F19.131

Other psychoactive substance abuse with withdrawal delirium

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F19.131 refers to a specific medical condition characterized by the misuse of psychoactive substances leading to a serious withdrawal state marked by delirium. This condition typically occurs when someone who has been regularly using certain substances stops or reduces intake suddenly, causing severe mental and physical symptoms. Recognizing and understanding this condition is essential for appropriate medical management and support.

Causes & Symptoms

Clinical Causes: Prolonged or heavy use of psychoactive substances such as alcohol, sedatives, hypnotics, or other drugs that alter mental state. Sudden cessation or significant reduction in the intake of these substances after regular use. Development of physical dependence on the substance, leading to withdrawal symptoms. Co-occurring mental health disorders that may complicate substance use and withdrawal processes.

Key Symptoms: Delirium characterized by confusion, disorientation, and hallucinations. Severe agitation or restlessness. Fluctuating levels of consciousness, ranging from drowsiness to coma. Physical signs such as tremors, sweating, increased heart rate, or elevated blood pressure. Possible seizures or convulsions. Sleep disturbances and vivid nightmares. Sensory disturbances, including visual or auditory hallucinations. Nausea, vomiting, or abdominal discomfort in some cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of this condition involves a thorough clinical evaluation by a healthcare professional, who will assess the patient's medical history, substance use patterns, and current symptoms. Specific laboratory tests, including blood tests and toxicology screens, may be utilized to detect recent substance use and monitor physiological responses. Additionally, neurological assessments might be conducted to evaluate cognitive and mental status.

Treatment Protocols: Hospitalization in severe cases to ensure safety and provide close monitoring. Administration of medications to manage symptoms, such as sedatives for agitation or seizures. Supportive care, including hydration, electrolyte correction, and nutritional support. Psychological support and counseling to address underlying substance dependence. Development of a long-term plan for substance abstinence and relapse prevention, often involving psychotherapy and support groups. Monitoring for potential complications, such as infections or other medical issues.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.131 a billable ICD-10 code?
Yes, F19.131 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.131?
Clinical documentation must specify the nature of Other psychoactive substance abuse with withdrawal delirium and any associated comorbidities for accurate reporting.

Cite this Clinical Reference